Compare NRIX & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRIX | AKR |
|---|---|---|
| Founded | 2009 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2020 | 1996 |
| Metric | NRIX | AKR |
|---|---|---|
| Price | $23.40 | $18.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $33.93 | $24.71 |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 10-08-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 4.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | $76,987,000.00 | ★ $410,757,000.00 |
| Revenue This Year | $799.42 | N/A |
| Revenue Next Year | N/A | $15.14 |
| P/E Ratio | ★ N/A | $70.37 |
| Revenue Growth | ★ 99.31 | 14.20 |
| 52 Week Low | $9.00 | $18.61 |
| 52 Week High | $28.23 | $23.03 |
| Indicator | NRIX | AKR |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 20.52 |
| Support Level | $22.56 | N/A |
| Resistance Level | $24.98 | $21.29 |
| Average True Range (ATR) | 0.92 | 0.32 |
| MACD | -0.18 | -0.03 |
| Stochastic Oscillator | 37.56 | 0.63 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: REIT Portfolio segment consists of high-quality retail properties located in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds the retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.